Nuveen’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
175,648
+119,232
+211% +$1.37M ﹤0.01% 2240
2025
Q4
$580K Hold
56,416
﹤0.01% 2818
2025
Q3
$327K Hold
56,416
﹤0.01% 3033
2025
Q2
$379K Sell
56,416
-10,600
-16% -$85.3K ﹤0.01% 2963
2025
Q1
$606K Sell
67,016
-20,490
-23% -$255K ﹤0.01% 2839
2024
Q4
$1.51M Sell
87,506
-42,360
-33% -$767K ﹤0.01% 2500
2024
Q3
$2.08M Buy
129,866
+7,004
+6% +$110K ﹤0.01% 2393
2024
Q2
$1.75M Buy
122,862
+65,725
+115% +$934K ﹤0.01% 2450
2024
Q1
$810K Sell
57,137
-23,373
-29% -$330K ﹤0.01% 2780
2023
Q4
$1.21M Buy
80,510
+7,148
+10% +$106K ﹤0.01% 2645
2023
Q3
$1.16M Buy
73,362
+16,548
+29% +$261K ﹤0.01% 2519
2023
Q2
$860K Buy
56,814
+43,827
+337% +$604K ﹤0.01% 2719
2023
Q1
$188K Buy
+12,987
New +$173K ﹤0.01% 2998
2022
Q2
Sell
-13,872
Closed -$130K 3477
2022
Q1
$130K Hold
13,872
﹤0.01% 3230
2021
Q4
$237K Buy
+13,872
New +$336K ﹤0.01% 3217

Other funds holding TRDA